Exploiting the selective accumulation of lipofuscin in senescent cells, the authors developed a targeted senolytic platform. As proof of concept, they show that selective delivery of dasatinib elicits senolysis with minimal toxicity, in vitro, in organoids and in mice.
- Sophia Magkouta
- Dimitris Veroutis
- Vassilis G. Gorgoulis
